An integrated-optic biosensor based on electro-optically modulated localized surface plasmon resonance (LSPR) is demonstrated. This biosensor utilizes the electro-optic effect to modulate the wave vector of incident lightwave used to excite localized surface plasmons. Electro-optically modulated LSPR results in the analyte-dependent variation of output intensity with the applied voltage. The linear regression slope of this relation is used to determine the analyte concentration. On the sensing region of LSPR biosensor, human serum albumin is self-assembled on gold nanoparticles in order to sense the beta-blocker concentration. The use of the presented biosensor has the features of no intensity drift problem, no absorption diversity problem in different sample media, and noise reduction by linear regression analysis.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2006) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: